CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: FINAL RESULTS

被引：0
|
作者：
Zaour, N. [1 ]
Heisel, O. [2 ]
Leteneux, C. [3 ]
Ma, P. [4 ]
机构：
[1] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[2] Syreon Corp, Vancouver, BC, Canada
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1657
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS10
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [41] Comparison of Intravitreal Bevacizumab versus Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia-6 Month Results
    Fonseca, S.
    Carneiro, A.
    Mendonca, L.
    Falcao, M.
    Branclao, E.
    Falcao-Reis, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [42] Long-term Results of Photodynamic Therapy for Choroidal Neovascularization in Japanese Patients With Pathologic Myopia
    Hayashi, Kengo
    Ohno-Matsui, Kyoko
    Shimada, Noriaki
    Moriyama, Muka
    Hayashi, Wakako
    Wang, Jiying
    Yoshida, Takeshi
    Tokoro, Takashi
    Mochizuki, Manabu
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (01) : 137 - 147
  • [43] Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition
    Sayanagi, Kaori
    Fujimoto, Satoko
    Hara, Chikako
    Fukushima, Yoko
    Kawasaki, Ryo
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition
    Kaori Sayanagi
    Satoko Fujimoto
    Chikako Hara
    Yoko Fukushima
    Ryo Kawasaki
    Shigeru Sato
    Hirokazu Sakaguchi
    Kohji Nishida
    Scientific Reports, 12
  • [45] Long-term outcomes of the intravitreal injection of ranibizumab for the treatment of choroidal neovascularization secondary to pathologic myopia
    Wasiluk, Ewa
    Wojnar, Malgorzata
    Obuchowska, Iwona
    Mariak, Zofia
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 833 - 839
  • [46] Laser Photocoagulation, Photodynamic Therapy, and Intravitreal Bevacizumab for the Treatment of Juxtafoveal Choroidal Neovascularization Secondary to Pathologic Myopia
    Parodi, Maurizio Battaglia
    Iacono, Pierluigi
    Papayannis, Alexandros
    Sheth, Saumil
    Bandello, Francesco
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (04) : 437 - 442
  • [47] Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study
    Yusuf, Imran H. H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 28 - 30
  • [48] Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia
    Pakzad-Vaezi, Kaivon
    Mehta, Hemal
    Mammo, Zaid
    Tufail, Adnan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (07) : 873 - 881
  • [49] Long-term outcomes of the intravitreal injection of ranibizumab for the treatment of choroidal neovascularization secondary to pathologic myopia
    Ewa Wasiluk
    Malgorzata Wojnar
    Iwona Obuchowska
    Zofia Mariak
    International Ophthalmology, 2020, 40 : 833 - 839
  • [50] Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results
    Cornut, P. -L.
    Poli, M.
    Feldman, A.
    El Chehab, H.
    Swalduz, B.
    Burillon, C.
    Denis, P.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2010, 33 (05): : 327 - 333
12345